Tianxin Yang Selected Research

site 1 membrane-bound transcription factor peptidase

1/2021	Site-1 Protease-Derived Soluble (Pro)Renin Receptor Contributes to Angiotensin II-Induced Hypertension in Mice.
1/2021	Soluble (pro)renin receptor induces endothelial dysfunction and hypertension in mice with diet-induced obesity via activation of angiotensin II type 1 receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tianxin Yang Research Topics

Disease

24	Hypertension (High Blood Pressure) 01/2021 - 06/2005
20	Neoplasms (Cancer) 01/2020 - 01/2007
10	Fibrosis (Cirrhosis) 01/2022 - 07/2012
10	Inflammation (Inflammations) 01/2022 - 01/2011
7	Proteinuria 01/2021 - 01/2010
6	Body Weight (Weight, Body) 11/2015 - 06/2005
5	Type 2 Diabetes Mellitus (MODY) 12/2015 - 01/2008
5	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015 - 01/2015
4	Polyuria 10/2020 - 12/2009
4	Diabetic Nephropathies (Diabetic Nephropathy) 01/2016 - 01/2013
4	Acute Kidney Injury (Acute Renal Failure) 01/2016 - 04/2004
4	Mitochondrial Diseases (Mitochondrial Disease) 08/2013 - 05/2011
3	Obesity 01/2021 - 01/2018
3	Chronic Renal Insufficiency 01/2021 - 01/2018
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 01/2015
3	Necrosis 01/2020 - 01/2015
3	Neoplasm Metastasis (Metastasis) 07/2019 - 05/2015
3	Dehydration (Water Stress) 01/2019 - 08/2005
3	Leukemia 01/2019 - 01/2015
3	Diabetes Insipidus 11/2018 - 03/2016
3	Ischemia 03/2017 - 10/2008
2	Neuromyelitis Optica (Devic's Disease) 03/2021 - 06/2020
2	Polydipsia 10/2020 - 03/2016
2	Albuminuria 01/2020 - 12/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 01/2010
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020 - 01/2019
2	Chronic Disease (Chronic Diseases) 12/2019 - 01/2017
2	Nephrogenic Diabetes Insipidus 01/2019 - 11/2017
2	Insulin Resistance 06/2018 - 01/2018
2	Lymphoma (Lymphomas) 11/2016 - 01/2015
2	Kidney Diseases (Kidney Disease) 01/2016 - 01/2016
2	Edema (Dropsy) 11/2015 - 06/2005
2	Disease Progression 10/2015 - 01/2012
2	Infections 01/2015 - 10/2012
2	Hematologic Neoplasms (Hematological Malignancy) 01/2015 - 01/2015
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2015 - 01/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 03/2014
2	Breast Neoplasms (Breast Cancer) 01/2015 - 01/2015

Drug/Important Bio-Agent (IBA)

12	Prorenin ReceptorIBA 01/2021 - 04/2015
11	Angiotensin IIIBA 01/2021 - 11/2008
11	SaltsIBA 10/2020 - 11/2006
9	Proteins (Proteins, Gene)FDA Link 06/2020 - 10/2007
8	ReninIBA 01/2021 - 07/2014
8	SodiumIBA 01/2017 - 11/2006
8	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016 - 06/2006
6	Desoxycorticosterone Acetate (DOCA)FDA Link 10/2020 - 10/2008
6	p38 Mitogen-Activated Protein KinasesIBA 11/2016 - 01/2015
5	AldosteroneIBA 03/2017 - 05/2011
5	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 05/2007
5	Prostaglandin-E SynthasesIBA 01/2013 - 12/2009
4	Dinoprostone (PGE2)FDA Link 12/2019 - 11/2008
4	Pharmaceutical PreparationsIBA 06/2018 - 10/2007
4	Aurora Kinase AIBA 11/2016 - 01/2015
4	plumbaginIBA 01/2015 - 03/2014
4	AcidsIBA 01/2015 - 07/2007
4	CXA-10IBA 12/2013 - 10/2008
4	Prostaglandins EIBA 01/2013 - 12/2009
3	Desoxycorticosterone (Deoxycorticosterone)IBA 10/2020 - 07/2011
3	Acetates (Acetic Acid Esters)FDA Link 10/2020 - 07/2011
3	CytokinesIBA 01/2020 - 02/2010
3	CalciumIBA 01/2020 - 01/2019
3	LithiumIBA 01/2019 - 12/2009
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2015 - 01/2013
3	MLN 8237IBA 01/2015 - 01/2015
3	ThiazolidinedionesIBA 11/2013 - 06/2006
2	Urea (Carbamide)FDA LinkGeneric 01/2022 - 01/2015
2	Hexosaminidases (Hexosaminidase)IBA 01/2022 - 12/2018
2	CreatinineIBA 01/2022 - 01/2015
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 10/2008
2	site 1 membrane-bound transcription factor peptidaseIBA 01/2021 - 01/2021
2	LigandsIBA 01/2021 - 01/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020 - 12/2013
2	CateninsIBA 11/2020 - 01/2015
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2020 - 06/2005
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 01/2019
2	Butyric Acid (Butanoic Acid)IBA 12/2019 - 01/2017
2	Riboflavin (Vitamin B2)FDA LinkGeneric 10/2019 - 07/2019
2	GYY 4137IBA 01/2019 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 06/2018 - 01/2018
2	Biological ProductsIBA 01/2018 - 01/2013
2	Vasopressins (Vasopressin)IBA 11/2017 - 03/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2015
2	danusertibIBA 11/2016 - 01/2015
2	Aurora KinasesIBA 11/2016 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2016 - 08/2005
2	Coloring Agents (Dyes)IBA 01/2016 - 02/2012
2	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2015 - 10/2015
2	Insulin (Novolin)FDA Link 12/2015 - 01/2008
2	Therapeutic UsesIBA 12/2015 - 01/2015
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2015 - 02/2015
2	Antineoplastic Agents (Antineoplastics)IBA 05/2015 - 01/2015
2	Beclin-1IBA 01/2015 - 01/2015
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2015 - 01/2015
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2015 - 01/2015
2	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2015 - 01/2015
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2015 - 01/2015
2	TOR Serine-Threonine KinasesIBA 01/2015 - 01/2015
2	CaspasesIBA 01/2015 - 01/2015

Therapy/Procedure

11	Therapeutics 01/2020 - 05/2009
9	Drug Therapy (Chemotherapy) 01/2020 - 01/2007